$0.73
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. The company is headquartered in Little Elm, Texas and currently employs 195 full-time employees. The company went IPO on 2001-05-04. The firm is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Country

US

CEO

Mr. Thomas Shaw

IPO date

2001

Employees

195

ISIN

US76129W1053

Key stats

Open

$0.70

Volume

8.08K

Market cap

$21.85M

Prev. close

$0.73

Impl / hst vl

-

Open interest

$0.00

$0.70

Day’s Range

$0.73

$0.60

52W Range

$0.79

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
0.54
P/B
0.29
Current ratio
-
Debt / Equity
0.02
ROE
-
Gross margin
-
Income growth
-164.75%
FCF growth
28.21

Analysts estimates

Earnings

Q2 ‘26 revenue
$7.20M
Q2 ‘26 net income
$2.77M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply